XML 55 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Outstanding
Common Stock
Value of Shares Held in Rabbi Trust at Cost
Deferred Compensation Obligation
Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2016 $ 864,690   $ 268 $ (4,277) $ 4,277 $ 451,664 $ 414,095 $ (1,337)
Beginning balance (in shares) at Dec. 31, 2016   27,005,813            
Net income 87,204           $ 87,204  
Other comprehensive loss (494)             (494)
Common Stock, Dividends, Per Share, Declared             $ 1.28  
Common dividend declared (34,997)           $ (34,997)  
Common stock issued for acquisition 23,468   4     23,464    
Common stock issued for acquisition (in shares)   369,286            
Proceeds from exercise of stock options, net of cash paid 214         214    
Proceeds from exercise of stock options (in shares)   19,340            
Stock based compensation 3,333         3,333    
Restricted stock awards issued, net of awards surrendered (in shares)   31,665            
Restricted stock awards issued, net of awards surrendered (1,422)   1     (1,423)    
Stock Issued During Period, Shares, Other   24,086            
Stock Issued During Period, Value, Other 1,636         1,636    
Increase (Decrease) in Deferred Compensation       (313) 313      
Ending balance (in shares) at Dec. 31, 2017   27,450,190            
Ending balance at Dec. 31, 2017 943,809   273 (4,590) 4,590 479,430 465,937 (1,831)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets [1] 177         542 (365)  
Prior Period Reclassification Adjustment [2] 0           397 (397)
Net income 121,622           $ 121,622  
Other comprehensive loss 1,886             1,886
Common Stock, Dividends, Per Share, Declared             $ 1.52  
Common dividend declared (42,051)           $ (42,051)  
Common stock issued for acquisition 42,474   5     42,469    
Common stock issued for acquisition (in shares)   528,353            
Proceeds from exercise of stock options, net of cash paid 184   0     184    
Proceeds from exercise of stock options (in shares)   23,195            
Stock based compensation 4,225         4,225    
Restricted stock awards issued, net of awards surrendered (in shares)   43,383            
Restricted stock awards issued, net of awards surrendered (1,371)   1     (1,372)    
Stock Issued During Period, Shares, Other   35,287            
Stock Issued During Period, Value, Other 2,712         2,712    
Increase (Decrease) in Deferred Compensation 0              
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits       (128) 128      
Ending balance (in shares) at Dec. 31, 2018   28,080,408            
Ending balance at Dec. 31, 2018 1,073,490   279 (4,718) 4,718 527,648 546,736 (1,173)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets [3] 0              
Net income 29,934              
Ending balance (in shares) at Dec. 31, 2018   28,080,408            
Ending balance at Dec. 31, 2018 1,073,490   279 (4,718) 4,718 527,648 546,736 (1,173)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets [3]             831 (831)
Net income 165,175           $ 165,175  
Other comprehensive loss 19,342             19,342
Common Stock, Dividends, Per Share, Declared             $ 1.76  
Common dividend declared (57,729)           $ (57,729)  
Common stock issued for acquisition 499,693   61     499,632    
Common stock issued for acquisition (in shares)   6,166,010            
Proceeds from exercise of stock options, net of cash paid 281         281    
Proceeds from exercise of stock options (in shares)   14,646            
Stock based compensation 4,403         4,403    
Restricted stock awards issued, net of awards surrendered (in shares)   50,080            
Restricted stock awards issued, net of awards surrendered (1,463)   1     (1,464)    
Stock Issued During Period, Shares, Other   66,244            
Stock Issued During Period, Value, Other 4,951   1     4,950    
Increase (Decrease) in Deferred Compensation 0              
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits       (17) 17      
Ending balance (in shares) at Dec. 31, 2019   34,377,388            
Ending balance at Dec. 31, 2019 $ 1,708,143   $ 342 $ (4,735) $ 4,735 $ 1,035,450 $ 654,182 $ 18,169
[1]
Represents adjustment needed to reflect the cumulative impact on retained earnings for previously recognized stock based compensation, which included an adjustment for estimated forfeitures. Pursuant to the Company's adoption of Accounting Standards Update 2016-09, the Company has elected to recognize stock based compensation without inclusion of a forfeiture estimate, and as such has recognized this adjustment to present retained earnings consistent with this election.
[2]
Represents adjustment needed to reflect the cumulative impact on retained earnings for reclassification of the income tax effects attributable to accumulated other comprehensive income, as a result of the Tax Cuts and Jobs Act (the "Tax Act"). Pursuant to the Company's adoption of Accounting Standards Update 2018-02, the Company has elected to reclassify amounts stranded in other comprehensive income to retained earnings.
[3]
Represents adjustment needed to reflect the cumulative impact on retained earnings for the classification and measurement of investments in equity securities. Pursuant to the Company's adoption of Accounting Standards Update 2016-01, the Company's investments in equity securities will no longer be classified as available for sale, therefore the Company was required to reclassify the net unrealized gain recognized on the change in fair value of these equity securities from other comprehensive income to retained earnings.